Cycclone, Inc. (CYCL)
Cycclone Inc., operating with its subsidiaries, specializes in the development, promotion, and distribution of bacteria-derived products. These offerings primarily function as beneficial additives for both agricultural crops and animal feed within the People's Republic of China. The company's product line includes various biological bacterium blends, notably those based on Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM). For crop cultivation, these AM/HM blends – exemplified by Bulgaria lactobacillus, beer microzyme, and dark red spirilla – are designed to boost beneficial microbial populations in soil, suppress harmful fungi and putrefactive bacteria, enhance nutrient absorption, and ultimately help mitigate diseases in crops and livestock. In the livestock sector, AM/HM-based feed additives serve to tenderize feed, inhibit the growth of pathogenic bacteria, and provide crucial nutrients such as organic acids, vitamins, enzymes, antibiotics, mycelium protein, and other growth stimulants, thereby ensuring a balanced nutritional intake. Furthermore, Cycclone offers FGW bacterial preservatives, utilized for preserving animal specimens in scientific research and extending the freshness of agricultural produce. It also supplies bacteria-based fertilizers for foliar application on fruits and vegetables. Beyond its biotechnology operations, the company holds investments in residential and commercial real estate. Founded in 2004 as China Dasheng Biotechnology Co., the company officially adopted the name Cycclone Inc. in May 2025 and is headquartered in Lanzhou, China.
Industry: Shell Companies
Cycclone Inc.
No splits on record
Nothing in CYCL's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2022 | FY 2007 | FY 2006 | FY 2005 | FY 2004 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2023-06-30 | 2008-06-30 | 2007-10-31 | 2006-10-31 | 2005-10-31 |
| Revenue | $0 | $0 | $0 | $16.29M | $0 | $485K | $631K |
| YoY Growth | - | - | - | - | - | -23.1% | - |
| Cost of Revenue | $20K | $26K | $0 | $8.79M | $2K | $365K | $407K |
| Gross Profit | -$20K | -$26K | $0 | $7.5M | -$2K | $120K | $224K |
| Gross Margin | - | - | - | 46.1% | - | 24.7% | 35.5% |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $52K | $98K | $561K | $2.43M | $8K | $137K | $247K |
| Other | $0 | $0 | $97K | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $52K | $98K | $657K | $2.43M | $8K | $137K | $247K |
| Operating Income (EBIT) | -$72K | -$124K | -$657K | $5.08M | -$10K | -$17K | -$23K |
| Operating Margin | - | - | - | 31.1% | - | -3.5% | -3.6% |
| Interest Expense | $0 | $0 | $360K | $42K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $159K | $0 | $0 | $0 |
| Other Income (Expense) | $0 | $910K | -$309K | $2.71M | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$72K | $787K | -$967K | $7.79M | -$10K | $0 | -$23K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$72K | $787K | -$967K | $4.64M | -$68K | -$17K | -$23K |
| Net Income Margin | - | - | - | 28.5% | - | -3.5% | -3.6% |
| Supplementary Data | |||||||
| EPS | -0.00 | 0.02 | -0.02 | 0.15 | -0.01 | -0.00 | -0.00 |
| Diluted EPS | -0.00 | 0.00 | -0.02 | 0.15 | -0.01 | -0.00 | -0.00 |
| Weighted Average OS | 40.98M | 40.98M | 40.98M | 30.00M | 9.80M | 9.10M | 9.10M |
| EBITDA | -$52K | -$98K | -$586K | $5.7M | -$8K | -$15K | -$21K |
| EBITDA Margin | - | - | - | 35.0% | - | -3.1% | -3.3% |
| Period | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2007 | FY 2005 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2023-06-30 | 2022-06-30 | 2008-06-30 | 2006-10-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $249 | $549 | $7K | $0 | $1.56M | $7K |
| Short-Term Investments | $0 | $0 | $118K | $0 | $0 | $0 |
| Cash and Short-Term Investments | $249 | $549 | $126K | $0 | $1.56M | $7K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $3.24M | $8K |
| Inventory | $0 | $0 | $0 | $0 | $562K | $21K |
| Other Current Assets | $0 | $0 | $0 | $0 | $3.07M | $0 |
| Total Current Assets | $7K | $549 | $126K | $0 | $8.47M | $36K |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $56K | $92K | $118K | $0 | $1.62M | $4K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $1.53M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $7.48M | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $233K | $0 | $1.15M | $8K |
| Total Long-Term Assets | $56K | $92K | $351K | $0 | $11.78M | $13K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $63K | $92K | $477K | $0 | $20.25M | $49K |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $0 | $30K | $46K | $0 | $726K | $0 |
| Short-Term Debt | $60K | $0 | $1.03M | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $40K | $0 | $0 | $0 |
| Other Current Liabilities | $30K | $0 | $576K | $30K | $0 | $0 |
| Total Current Liabilities | $91K | $30K | $1.69M | $30K | $1.54M | $49K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $1.46M | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $1.46M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $91K | $30K | $1.69M | $30K | $2.99M | $49K |
| Stockholders' Equity | ||||||
| Preferred Stock | $840 | $840 | $840 | $0 | $0 | $0 |
| Common Stock | $41K | $41K | $41K | $41K | $30K | $9K |
| Retained Earnings | -$1.06M | -$990K | -$1.47M | $0 | $8.01M | -$9K |
| Comprehensive Income & Other | -$3K | $19.07M | $49K | $0 | $3.81M | $0 |
| Other Stockholders' Equity | $993K | $1.01M | $215K | -$71K | $7.65M | $0 |
| Total Equity | -$28K | $62K | -$1.21M | -$30K | $15.69M | -$381 |
| Minority Interest | $0 | $0 | $0 | $0 | $1.56M | $0 |
| Total Liabilities and Equity | $63K | $92K | $477K | $0 | $18.69M | $49K |
| Supplementary Data | ||||||
| Total Debt | $60K | $0 | $1.03M | $0 | $0 | $0 |
| Net Debt | $60K | -$549 | $1.02M | $0 | -$1.56M | -$7K |
| Period | FY 2025 | FY 2024 | FY 2022 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2023-06-30 | 2008-06-30 | 2007-10-31 | 2006-10-31 |
| Operating Activities | ||||||
| Net Income | -$72K | $787K | -$967K | $4.64M | -$68K | -$17K |
| Depreciation & Amortization | $20K | $26K | $21K | $626K | $2K | $2K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $0 | $0 | $0 | $195K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $272K | $21K | $1K |
| Accounts Payable | $0 | $840 | $0 | -$227K | $0 | $0 |
| Other Working Capital | $511 | $0 | $44K | -$2.02M | $30K | $20K |
| Total Working Capital Change | $511 | $840 | $44K | -$1.78M | $51K | $21K |
| Other Non-Cash Items | -$785 | -$910K | $669K | $616K | $0 | $0 |
| Net Cash from Operating | -$53K | -$97K | -$234K | $4.1M | -$16K | $6K |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $0 | $0 | -$31K | $0 | $0 |
| Acquisitions | $0 | $0 | $6K | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | -$5.1M | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $1.22M | $8K | $0 |
| Net Cash from Investing | $0 | $0 | $6K | -$3.92M | $8K | $0 |
| Financing Activities | ||||||
| Debt Repaid | - | - | - | $1.1M | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $900 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $238K | $177K | $0 | $0 |
| Net Cash from Financing | $59K | $97K | $334K | -$927K | $900 | $0 |
| Forex Effect | -$6K | -$1.56M | -$100K | $991K | $0 | $0 |
| Net Change in Cash | -$300 | -$1.56M | $7K | $245K | -$7K | $6K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$53K | -$97K | -$234K | $4.1M | -$16K | $6K |
| Capital Expenditure | $0 | $0 | $0 | -$31K | $0 | $0 |
| Free Cash Flow | -$53K | -$97K | -$234K | $4.07M | -$16K | $6K |
| Cash at Beginning | $549 | $1.56M | $0 | $1.32M | $7K | $1K |
| Cash at End | $249 | $549 | $7K | $1.56M | $0 | $7K |